Silicon-based synthetic DNA manufacturing for life sciences research
Twist Bioscience manufactures synthetic DNA using a proprietary silicon-based process, serving researchers in medicine, agriculture, and industrial chemicals. The company is mid-scale (501–1,000 employees) with a sales-led hiring profile (26 active sales roles vs. 13 engineering) and decelerating hiring velocity. Current focus spans NGS workflow optimization, antibody discovery projects, and ERP/CPQ system enhancements—alongside pain points around revenue forecasting and production scheduling—indicating tension between scaling manufacturing capacity and sales velocity.
Notable leadership hires: CRM Director
Twist Bioscience is a publicly traded synthetic biology company that designs and manufactures synthetic DNA for life science research and development. The platform includes gene synthesis, oligonucleotide pools, biopharma services, and NGS target enrichment tools. Researchers use the product across drug discovery, gene therapy, and industrial biotech workflows. The company operates manufacturing facilities and technical services from South San Francisco, with hiring footprint across the United States, Sweden, Uganda, Singapore, and the United Kingdom. Salesforce (Sales Cloud, Data Cloud, Marketing Cloud) and AWS form the core commercial and cloud infrastructure; LIMS, Nextflow, and MES systems manage lab workflows and production.
Twist uses a proprietary silicon-based manufacturing process. The platform sits on Salesforce, AWS, Docker, Kubernetes, Python, Nextflow, and specialized lab systems (LIMS, MES, TapeStation, Qubit) for quality control and sequencing workflows.
Headquartered in South San Francisco, California. Actively hiring in the United States, Sweden, Uganda, Singapore, and the United Kingdom.
Other companies in the same industry, closest in size